| Evaluation of a novel Tc-99m labelled vitamin B<sub>12</sub> derivative for targeting <em>Escherichia coli</em> and <em>Staphylococcus aureus In Vitro</em> and in an experimental foreign-body infection model
Baldoni, D., Waibel, R., Bläuenstein, P., Galli, F., Iodice, V., Signore, A., … Trampuz, A. (2015). Evaluation of a novel Tc-99m labelled vitamin B12 derivative for targeting Escherichia coli and Staphylococcus aureus In Vitro and in an experimental foreign-body infection model. Molecular Imaging and Biology, 17(6), 829-837. https://doi.org/10.1007/s11307-015-0832-x |
| Tumor imaging in patients with advanced tumors using a new <sup>99m</sup>Tc-radiolabeled vitamin B12 derivative
Sah, B. R., Schibli, R., Waibel, R., Von Boehmer, L., Bläuenstein, P., Nexo, E., … Burger, I. A. (2014). Tumor imaging in patients with advanced tumors using a new 99mTc-radiolabeled vitamin B12 derivative. Journal of Nuclear Medicine, 55(1), 43-49. https://doi.org/10.2967/jnumed.113.122499 |
| The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms
Yang, Y., Neef, T., Mittelholzer, C., Garcia Garayoa, E., Bläuenstein, P., Schibli, R., … Burkhard, P. (2013). The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms. Journal of Nanobiotechnology, 11(1), 36 (10 pp.). https://doi.org/10.1186/1477-3155-11-36 |
| PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with <sup>177</sup>Lu-DOTA-bombesin analogues
Däpp, S., Müller, C., Garayoa, E. G., Bläuenstein, P., Maes, V., Brans, L., … Schibli, R. (2012). PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues. EJNMMI Research, 2(1), 24 (12 pp.). https://doi.org/10.1186/2191-219X-2-24 |
| A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours
García-Garayoa, E., Bläuenstein, P., Blanc, A., Maes, V., Tourwé, D., & Schubiger, P. A. (2009). A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours. European Journal of Nuclear Medicine and Molecular Imaging, 36(1), 37-47. https://doi.org/10.1007/s00259-008-0894-y |
| In-line radiolabeling: a novel continuous-flow system for commercial-scale protein labeling
Harris, D. A., Pellikka, R., Gasser, O., Blaeuenstein, P., Waibel, R., Schubiger, P. A., … Parseghian, M. H. (2009). In-line radiolabeling: a novel continuous-flow system for commercial-scale protein labeling. Journal of Nuclear Medicine, 50(7), 1178-1186. https://doi.org/10.2967/jnumed.108.056812 |
| Glycation methods for bombesin analogs containing the (<em>N</em><sup>α</sup>His)Ac chelator for <sup>99m</sup>Tc(CO)<sub>3</sub> radiolabeling
Brans, L., Maes, V., García-Garayoa, E., Schweinsberg, C., Daepp, S., Bläuenstein, P., … Tourwé, D. A. (2008). Glycation methods for bombesin analogs containing the (NαHis)Ac chelator for 99mTc(CO)3 radiolabeling. Chemical Biology and Drug Design, 72(6), 496-506. https://doi.org/10.1111/j.1747-0285.2008.00727.x |
| Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [<sup>99m</sup>Tc(CO)<sub>3</sub>]-core
García Garayoa, E., Schweinsberg, C., Maes, V., Brans, L., Bläuenstein, P., Tourwé, D. A., … Schubiger, P. A. (2008). Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core. Bioconjugate Chemistry, 19(12), 2409-2416. https://doi.org/10.1021/bc800262m |
| Novel glycated [<sup>99m</sup>Tc(CO)<sub>3</sub>]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors
Schweinsberg, C., Maes, V., Brans, L., Bläuenstein, P., Tourwé, D. A., Schubiger, P. A., … García Garayoa, E. (2008). Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. Bioconjugate Chemistry, 19(12), 2432-2439. https://doi.org/10.1021/bc800319g |
| Chemical and biological characterization of new Re(CO)<sub>3</sub>/[<sup>99m</sup>Tc](CO)<sub>3</sub> bombesin analogues
García Garayoa, E., Rüegg, D., Bläuenstein, P., Zwimpfer, M., Khan, I. U., Maes, V., … Schubiger, P. A. (2007). Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues. Nuclear Medicine and Biology, 34(1), 17-28. https://doi.org/10.1016/j.nucmedbio.2006.10.004 |
| New [<sup>99m</sup>Tc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors
García Garayoa, E., Schweinsberg, C., Maes, V., Rüegg, D., Blanc, A., Bläuenstein, P., … Schubiger, P. A. (2007). New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 51(1), 42-50. |
| Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors
García-Garayoa, E., Maes, V., Bläuenstein, P., Blanc, A., Hohn, A., Tourwé, D., & Schubiger, P. A. (2006). Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors. Nuclear Medicine and Biology, 33(4), 495-503. https://doi.org/10.1016/j.nucmedbio.2006.01.007 |
| Novel <sup>99m</sup>Tc-labeled neurotensin analogues with optimized biodistribution properties
Macs, V., Garcia-Garayoa, E., Bläuenstein, P., & Tourwé, D. (2006). Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties. Journal of Medicinal Chemistry, 49(5), 1833-1836. https://doi.org/10.1021/jm051172f |
| <em>In vivo</em> evaluation of <sup>177</sup>Lu- and <sup>67/64</sup>Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors
Grünberg, J., Novak-Hofer, I., Honer, M., Zimmermann, K., Knogler, K., Bläuenstein, P., … Schubiger, P. A. (2005). In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors. Clinical Cancer Research, 11(14), 5112-5120. https://doi.org/10.1158/1078-0432.CCR-05-0227 |
| Improving the tumor uptake of <sup>99m</sup>Tc-labeled neuropeptides using stabilized peptide analogues
Bläuenstein, P., García Garayoa, E., Rüegg, D., Blanc, A., Tourwé, D., Beck-Sickinger, A., & Schubiger, P. A. (2004). Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues. Cancer Biotherapy and Radiopharmaceuticals, 19(2), 181-188. https://doi.org/10.1089/108497804323071959 |
| Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [<sup>123</sup>I]iododeoxyuridine
Buchegger, F., Vieira, J. M., Blaeuenstein, P., Dupertuis, Y. M., Schaffland, A. O., Grannavel, C., … Delaloye, A. B. (2003). Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridine. European Journal of Nuclear Medicine and Molecular Imaging, 30, 239-246. https://doi.org/10.1007/s00259-002-1049-1 |
| <em>In vitro</em> and <em>in vivo</em> evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors
García-Garayoa, E., Allemann-Tannahill, L., Bläuenstein, P., Willmann, M., Carrel-Rémy, N., Tourwé, D., … Schubiger, P. A. (2001). In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors. Nuclear Medicine and Biology, 28(1), 75-84. https://doi.org/10.1016/S0969-8051(00)00190-6 |
| [<sup>76</sup>Br]Bromodeoxyuridine PET in tumor-bearing animals
Gardelle, O., Roelcke, U., Vontobel, P., Crompton, N. E. A., Guenther, I., Bläuenstein, P., … Kaser-Hotz, B. (2001). [76Br]Bromodeoxyuridine PET in tumor-bearing animals. Nuclear Medicine and Biology, 28(1), 51-57. https://doi.org/10.1016/S0969-8051(00)00189-X |
| [<sup>76</sup>Br]bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography,<em> in vitro</em> and<em> in vivo</em> studies in mice
Ryser, J. E., Bläuenstein, P., Rémy, N., Weinreich, R., Hasler, P. H., Novak-Hofer, I., & Schubiger, P. A. (1999). [76Br]bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice. Nuclear Medicine and Biology, 26(6), 673-679. https://doi.org/10.1016/S0969-8051(99)00042-6 |
| Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides
Schubiger, P. A., Allemann-Tannahill, L., Egli, A., Schibli, R., Alberto, R., Carrel-Remy, N., … Tourwe, D. (1999). Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides. Quarterly Journal of Nuclear Medicine, 43(2), 155-158. |
